Prognostic implication of transforming growth factor alpha in adenocarcinoma of the lung--an immunohistochemical study

Br J Cancer. 1991 Jan;63(1):130-3. doi: 10.1038/bjc.1991.26.

Abstract

We examined for transforming growth factor alpha (TGF alpha) in adenocarcinomatous lesions of the lung tissues excised from 138 patients, with use of the avidin-biotin-peroxidase complex (ABC) method. TGF alpha was present in the cytoplasm of the adenocarcinoma. Our objective was to determine if TGF alpha could serve as a prognostic parameter. We divided 138 patients into two groups according to the concentration of TGF alpha. Ninety-two patients had a high concentration of TGF alpha, in over 75% of the tumour cells, while 46 had a low concentration, that is in less than 75% of the cells. The 5-year survival rates of patients with high TGF alpha and low TGF alpha were 39% and 64%, respectively (P less than 0.05). Our data suggest that evidence of a high immunoreactivity of TGF alpha can serve as a prognostic parameter in adenocarcinoma of the lung.

Publication types

  • Comparative Study

MeSH terms

  • Adenocarcinoma / metabolism*
  • Adult
  • Aged
  • Aged, 80 and over
  • Cytoplasm / metabolism
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Immunohistochemistry
  • Lung Neoplasms / metabolism*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Prognosis
  • Transforming Growth Factor beta / metabolism*

Substances

  • Transforming Growth Factor beta